OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Sarah Houlton, PhD, is Pharmaceutical Executive’s international correspondent.
It could be the end of the road for the UK's biotech firms if drastic action isn't taken soon.
The new EU directive looks to reduce, refine, and eventually replace animal testing
EU makes plans to police its supply chain
Will the sole-wholesaler approach mean higher costs for NHS?
Pharma defends itself against claims made in charity's report on drug access for the world's poor
One of industry's main complaints is that delaying the introduction of new medicines is a particularly simple way of saving money